Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Januar 2024 07:30 ET | Quelle: Optimi Health Corp.

Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence

Optimi Health granted amendment to its Health Canada Controlled Drugs and Substances Licence.
04. April 2023 07:00 ET | Quelle: Vantage Hemp

Vantage Hemp Co. Submits Drug Master File for CBD Isolate to the U.S. Food & Drug Administration

Greeley, Colorado, April 04, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF) for its cannabidiol (CBD) Isolate to the...
13. April 2022 04:58 ET | Quelle: Research and Markets

Global $250+ Bn Pharmaceutical API Manufacturing (Chemical & Biological) Markets, 2016-2021, 2021-2026F, 2031F

Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. ...
24. Januar 2022 07:45 ET | Quelle: Vantage Hemp

Vantage Hemp Co. is in the Final Stages of its DMF Submissions

Greeley, Colorado, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), an industry-leading manufacturer of pharmaceutical-grade CBD products, today announced that the...